Hastings Center Report 32 (4):46-47 (2002)
| Abstract |
"Dying in the City of Blues: Sickle Cell Anemia and the Politics of Race and Health" by Keith Wailoo is reviewed.
|
| Keywords | No keywords specified (fix it) |
| Categories | (categorize this paper) |
| DOI | 10.2307/3528090 |
| Options |
Mark as duplicate
Export citation
Request removal from index
|
Download options
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Genetic Marker of Segregation: Sickle Cell Anemia, Thalassemia, and Racial Ideology in American Medical Writing 1920-1950.Keith Wailoo - 1996 - History and Philosophy of the Life Sciences 18 (3):305 - 320.
Sickle Cell Disease and the “Difficult Patient” Conundrum.Edward J. Bergman & Nicholas J. Diamond - 2013 - American Journal of Bioethics 13 (4):3 - 10.
Intractable Difficulties in Caring for People With Sickle Cell Disease.Helen Jane Crowther & Ian Kerridge - 2013 - American Journal of Bioethics 13 (4):22 - 24.
Disrespectful Care in the Treatment of Sickle Cell Disease Requires More Than Ethics Consultation.Carlton Haywood - 2013 - American Journal of Bioethics 13 (4):12 - 14.
Not Your Typical Frequent Flyer: Overcoming Mythology in Caring for Sickle Cell Disease Patients.Dowin H. Boatright & Jean Abbott - 2013 - American Journal of Bioethics 13 (4):18 - 20.
Working Up Policy : The Use of Specific Disease Exemplars in Formulating General Principles Governing Childhood Genetic Testing. [REVIEW]Paula Boddington & Susan Hogben - 2006 - Health Care Analysis 14 (1):1-13.
The “Difficult Patient” Conundrum in Sickle Cell Disease in Kenya: Complex Sociopolitical Problems Need Wide Multidimensional Solutions.Vicki Marsh, George Mocamah, Emmanuel Mabibo, Francis Kombe & Thomas N. Williams - 2013 - American Journal of Bioethics 13 (4):20 - 22.
Family Study in Sickle Cell Disease in Nigeria.F. E. A. Lesi & Ekpo E. E. Bassey - 1972 - Journal of Biosocial Science 4 (3):307-313.
Pathways of Innovation: A History of the First Effective Treatment for Sickle Cell Anemia.Valerie L. Williams - 2004 - Perspectives in Biology and Medicine 47 (4):552-563.
Ethical Issues Related to Computerised Family Medical Histories in Sickle Cell Disease: Inforare.S. Franrenet, N. Duchange, F. Galacteros, C. Quantin, O. Cohen, R. Nzouakou, S. Sudraud, C. Herve & G. Moutel - 2010 - Journal of Medical Ethics 36 (10):604-607.
Patient-Controlled Analgesia: Advantages, Disadvantages, and Ethical Issues in the Management of Pain in Sickle Cell Disease.Veronica Thomas - 2002 - In K. W. M. Fulford, Donna Dickenson & Thomas H. Murray (eds.), Healthcare Ethics and Human Values: An Introductory Text with Readings and Case Studies. Blackwell. pp. 252.
Molecular Diseases and Diseased Molecules: Ontological and Epistemological Dimensions.Bruno J. Strasser & Bernardino Fantini - 1998 - History and Philosophy of the Life Sciences 20 (2):189 - 214.
Tensions and Opportunities in Convergence: Shifting Concepts of Disease in Emerging Molecular Medicine. [REVIEW]Marianne Boenink - 2009 - NanoEthics 3 (3):243-255.
Would You Terminate a Pregnancy Affected by Sickle Cell Disease?: Analysis of Views of Patients in Cameroon.Ambroise Wonkam, Jantina de Vries, Charmaine Royal, Raj Ramesar & I. I. I. Fru Angwafo - 2014 - Journal of Medical Ethics 40 (9):615-620.
Analytics
Added to PP index
2013-11-22
Total views
15 ( #643,942 of 2,403,526 )
Recent downloads (6 months)
3 ( #256,481 of 2,403,526 )
2013-11-22
Total views
15 ( #643,942 of 2,403,526 )
Recent downloads (6 months)
3 ( #256,481 of 2,403,526 )
How can I increase my downloads?
Downloads
